ArticleJournal of gastrointestinal oncology2026

PD-1 inhibitors combined with tyrosine kinase inhibitors for conversion therapy in patients with unresectable hepatocellular carcinoma: a retrospective cohort study.

Gang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.